25 of the Best Oncologists Near Me in Ledgewood, NJ

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Alistar is board certified in American Board Of Internal Medicine. Dr. Alistar is currently accepting new patients.

Naveed Jan is a Hematologist and an Oncologist practicing medicine in Denville, New Jersey. Dr. Jan is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, and Vitamin B12 Deficiency. Dr. Jan is board certified in American Board Of Internal Medicine. Dr. Jan is currently accepting new patients.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration. Dr. Cherry is board certified in American Board Of Internal Medicine. Dr. Cherry is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration. Dr. Scola is board certified in American Board Of Internal Medicine. Dr. Scola is currently accepting new patients.

May Matkiwsky is a Hematologist and an Oncologist practicing medicine in Sparta, New Jersey. Dr. Matkiwsky is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Drug-Induced Thrombocytopenia, and Bone Marrow Aspiration. Dr. Matkiwsky is board certified in American Board Of Internal Medicine. Dr. Matkiwsky is currently accepting new patients.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Early is board certified in American Board Of Internal Medicine. Dr. Early is currently accepting new patients.

Anita Kumar is a Hematologist and an Oncologist practicing medicine in Basking Ridge, New Jersey. She has been practicing medicine for over 18 years. Dr. Kumar is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Gastric Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Kumar is currently accepting new patients.

Since 1999, Dr. Daniel Tobias has been a gynecologic oncologist at Atlantic Health System’s Women’s Cancer Center, diagnosing and treating conditions of the female reproductive system. He is dual board-certified in obstetrics and gynecology and gynecologic oncology, and he is part of Atlantic Medical Group with privileges at both Morristown and Overlook medical centers. He is currently the director of gynecologic oncology for Atlantic Health System.Dr. Tobias attended the University of Missouri-Kansas City School of Medicine for an integrated six-year combined bachelors of arts and medical degree program. He performed his residency at Albert Einstein College of Medicine’s Montefiore Medical Center and his fellowship in gynecologic oncology at Mount Sinai School of Medicine in New York. During his fellowship, Dr. Tobias served as principal investigator of a study initiated by the New York Gynecologic Oncology Group. Keenly interested in research, Dr. Tobias continues to bring clinical trials and research to his patients.As part of an integrated care team, Dr. Tobias treats gynecologic malignancies using a combination of modalities and advanced technologies to spare healthy tissue. His medical career includes many honors, awards, presentations and authored works.Dr. Tobias is affiliated with and involved in several professional societies including the Society of Gynecology Oncologists and the American College of Obstetricians and Gynecologists. He has extensive experience with radical surgery, intraperitoneal chemotherapy and laparoscopic surgery. Dr. Tobias has performed robotic surgery since 2005, helped develop a comprehensive gynecologic oncology robotics program, and trains other physicians to perform robotics surgery. He also participates in resident education. Dr. Tobias is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tobias is board certified in American Board Of Obstetrics And Gynecology. Dr. Tobias is currently accepting new patients.

Nana Tchabo, MD, FACOG Dr. Nana Tchabo is dual board certified in gynecology-oncology and obstetrics and gynecology, with fellowship training in minimally invasive gynecologic surgery and robotic procedures. A native of Baltimore, MD, Dr. Tchabo is a gynecologic oncologist at Atlantic Health System’s Morristown and Overlook Medical Centers Women’s Cancer Center, part of the Atlantic Medical Group. After graduating from Brown University in 1996 with a bachelor’s degree in neuroscience and a minor in women’s health, Dr. Tchabo attended Brown University School of Medicine for her medical degree, where she was cited for academic excellence. Dr. Tchabo completed her residency in obstetrics and gynecology at Georgetown University in 2004 and pursued additional research training at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, and gynecologic oncology fellowship training at Roswell Park Cancer Institute in Buffalo, NY. Committed to cancer prevention and survivorship, Dr. Tchabo is a principal investigator on many of the gynecologic cancer clinical research trials available at the Carol G. Simon Cancer Center. She also serves as associate residency director for Gynecology at Overlook Medical Center. Dr. Tchabo is an assistant clinical professor at the Sidney Kimmel Medical College of Thomas Jefferson University and is a former assistant clinical professor at Mount Sinai School of Medicine’s department of Obstetrics, Gynecology and Reproductive Science. Dr. Tchabo is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tchabo is board certified in American Board Of Obstetrics And Gynecology. Dr. Tchabo is currently accepting new patients.

Jason Knight is a Gynecologic Oncologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Knight is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Oophorectomy, and Hysterectomy. Dr. Knight is currently accepting new patients.

Sarada Gurubhagavatula is a Hematologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Gurubhagavatula is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Familial Pancreatic Cancer. Dr. Gurubhagavatula is board certified in American Board Of Internal Medicine. Dr. Gurubhagavatula is currently accepting new patients.

Dr. Waina Cheng is a medical oncologist hematologist dedicated to the diagnosis and treatment of all types of cancer and blood disorders. Her primary interest is in breast and colon cancer. She also has extensive experience in diagnosing and treating benign blood conditions. Dr Cheng is board-certified in hematology and oncology. She completed her residency and fellowship training at New York-Presbyterian Hospital in New York City. She received her medical degree from the Icahn School of Medicine at Mount Sinai in New York. Before joining Atlantic Medical Oncology, Dr. Cheng served as assistant professor of clinical medicine at Lincoln Medical Center, affiliated with Weill Cornell Medical College. There, she strived to provide quality cancer care for the underserved immigrant population of the South Bronx community. For her work there, she was awarded a scholarship from the Susan G. Komen and Conquer Cancer Foundation for her commitment to practicing in a medically underserved population. To better improve coordination of care for cancer patients, she served as quality improvement liaison in the cancer committee. Dr. Cheng currently serves as chair of the American College of Surgeons Commission on Cancer-accredited Cancer Committee at Newton Medical Center. She maintains professional membership in the American Society of Clinical Oncology, is a part of the Atlantic Medical Group and is a participating provider of the Atlantic Accountable Care Organization. Dr. Cheng is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, Muscle Invasive Bladder Cancer, and Bone Marrow Aspiration. Dr. Cheng is board certified in American Board Of Internal Medicine. Dr. Cheng is currently accepting new patients.

David Gallinson is a Hematologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Gallinson is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Anemia, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration. Dr. Gallinson is board certified in American Board Of Internal Medicine. Dr. Gallinson is currently accepting new patients.

William Rafelson, MD, MBA, is a fellowship-trained hematologist-oncologist with Atlantic Medical Group (AMG). Board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine, he has a focus in the management of advanced genitourinary cancers (cancers arising from the bladder, urinary tract, kidney, prostate, or testes), and treats a range of hematologic and oncologic disorders. He believes in providing compassionate care and uses a shared decision-making approach in tailoring the right treatment regimen, whether that is chemotherapy, hormone therapy, or immunotherapy to treat the patient’s disease.After earning his medical degree at the UMDNJ-Robert Wood Johnson Medical School at Camden, NJ, Dr. Rafelson completed an internal medicine residency at The Warren Alpert Medical School of Brown University, Providence, RI, served as a National Institutes of Health (NIH) T32 post-doctoral research fellow at Rhode Island Hospital, also in Providence, followed by fellowship in Hematology/Oncology, again at Warren Alpert School of Medicine. He also holds an MBA from the Heller School for Social Policy and Management, Brandeis University, Waltham, MA. Prior to joining AMG, he served as assistant attending in the Solid Tumor Genitourinary Oncology service at Memorial Sloan Kettering Cancer Center in Middletown, NJ, and served on the inpatient genitourinary service in Memorial Hospital in New York City.The author of multiple publications in peer-reviewed medical journals, Dr. Rafelson has also written several chapters in medical textbooks, including Ferri’s Clinical Advisor. He won a National Research Service Postdoctoral Award from the NIH and was one of just 15 medical oncologists nationally to be selected for a Rising Star Award from Castle Connolly. He was selected as one of “Jersey’s Best” medical oncologists in 2022 and 2023.Prior to joining AMG, Dr. Rafelson served as Instructor of Medicine and, later, Assistant Professor of Medicine at Weill Cornell Medical College, Cornell University, New York City, teaching first- and second-year medical students. He is a member of the American Society for Clinical Oncology and the American College of Physicians. He attends the MSKCC Annual Hematology-Oncology Review as well as ASCO annual conferences yearly to apply the most up-to-date information in his specialty. Dr. Rafelson is a participating provider of the Atlantic Accountable Care Organization. Dr. Rafelson is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer. Dr. Rafelson is board certified in American Board Of Internal Medicine. Dr. Rafelson is currently accepting new patients.

Neil S. Nimkar, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, he is trained in all malignancies and blood disorders. His clinical interests include anemia; hematology - WBC disorders; breast, colorectal, gastrointestinal, head and neck, and urological cancer (GU); leukemia and lymphoma. Dr. Nimkar strives to provide care individualized to the needs of each patient, while incorporating the most up-to-date knowledge and using precision medicine approach in treating patients. He takes pride in delivering the highest quality of patient care.After earning his medical degree at Ross University School of Medicine in Barbados, Dr. Nimkar completed his internal medicine residency at New York-Presbyterian Brooklyn Methodist Hospital in Brooklyn, NY, where he also performed his hematology-oncology fellowship. He received awards for excellence in clinical documentation as a best patient advocate, best ambulatory resident and as a wellness warrior. Dr. Nimkar joined ACOHA in 2021 following his fellowship training.In addition to English, Dr. Nimkar is fluent in Hindi and Gujarati. He has been published several times in peer-reviewed medical journals. His recent published research includes immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction, and he conducted an extensive study analyzing causes for the overtransfusion of blood products of patients. Dr. Nimkar is a participating provider of the Atlantic Accountable Care Organization. Dr. Nimkar is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Melanoma. Dr. Nimkar is board certified in American Board Of Internal Medicine. Dr. Nimkar is currently accepting new patients.

Shannon Tomita, MD, is a fellowship-trained gynecologic oncologist with Atlantic Women’s Cancer Associates, specializing in cancers of the female reproductive system. She has comprehensive clinical experience with women of all ages and applies her knowledge and skills to detect, treat, and cure cancer in her patients. With an interest in advancing women’s health, Dr. Tomita is privileged to care for women with cancer and compassionate in her approach. She is proficient in minimally invasive procedures such as gynecologic robotic and laparoscopic surgery and was the recipient of the Resident’s Achievement Award for excellence in laparoscopic surgery by the Society of Laparoendoscopic Surgeons. Out of the operating room, she is also skilled at administering chemotherapy as well as targeted and novel therapeutics in the treatment of gynecologic malignancies. In addition to her expertise in managing complex gynecologic cancers Dr. Tomita has collaborated on research into the early detection of gynecologic cancer, understanding the genetics of ovarian cancer, and the treatment of endometrial, ovarian, and other cancers of the female reproductive system. She is a member of the Society of Gynecological Oncology. After earning her degree from the State University of New York Downstate, Dr. Tomita completed her residency at Mount Sinai West/Mount Sinai St. Luke’s, in NYC. Following this, she spent two years in the Mount Sinai Ovarian Cancer Translational Research Lab in the Department of Genetics and Genomic Sciences, after which she pursued fellowship training at the Icahn School of Medicine at Mount Sinai, a program at the forefront of providing the highest level of care and robust training in gynecologic oncology. Dr. Tomita is a participating provider of the Atlantic Accountable Care Organization. Dr. Tomita is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Endometrial Cancer, Oophorectomy, and Hysterectomy. Dr. Tomita is board certified in American Board Of Obstetrics And Gynecology. Dr. Tomita is currently accepting new patients.

Dual board-certified in hematology and medical oncology, Dr. Gupta brings over a decade of clinical and research experience and expertise to Atlantic Medical Group. Dr. Gupta works closely with multidisciplinary groups in diagnosis and management of early stage and advanced breast cancers, and cancers of the head and neck area. She closely collaborates with physicians in surgical oncology and radiation oncology to deliver outstanding care to her patients and their family. She also treats benign hematology disorders such as anemia, and other blood abnormalities.Dr. Gupta completed her medical school at one of the best institutions in India and then went on to complete her internal medicine residency and hematology and oncology fellowship at Staten Island University Hospital, Northwell Health. After completing her education, she served as Assistant Professor of Medicine at Northwell Health System in Staten Island. She was also faculty member at State University of New York (SUNY Downstate) during her association with Staten Island Hospital. She subsequently joined the faculty at Weill Cornell Medical Center, New York Presbyterian Hospital, where she continued her commitment to excellent patient care.Dr. Gupta is also an active volunteer for the American Society of Clinical Oncology (ASCO), and continues to participate in various endeavors towards improvement in cancer care at a global level. She is widely published, and has won awards for her research and publications. She continues to actively enroll patients in breast oncology and head and neck oncology and serves as the principal investigator for several clinical trials within Atlantic Health System.Dr. Gupta is also the Associate Program Director of the Hematology and Oncology Fellowship Program at Atlantic Health System, and continues to mentor and train residents and fellows.Fluent in English and Hindi, Dr. Gupta is part of Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization. Dr. Gupta is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Thrombocytopenia. Dr. Gupta is board certified in American Board Of Internal Medicine. Dr. Gupta is currently accepting new patients.

Seyoung Han, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, hematology and medical oncology by the American Board of Internal Medicine, he has comprehensive experience and specialized training in treating blood diseases and various forms of cancer. Dr. Han’s clinical interests include lung, breast, GI, and hematologic cancers. He also participates in clinical trials as a principal investigator.Dr. Han meticulously analyzes each patient’s test results, takes detailed notes on their medical history, and performs thorough physical examinations in order to determine the most appropriate treatment options for each of his patients. He values informed decision-making to help patients maintain their quality of life. He provides patient-centered compassionate care and ensures that his patients have a full understanding of their condition and provides evidence-based treatment options.After earning his medical degree at Kyung Hee University College of Medicine in South Korea, and a compulsory three-year hitch in military service, Dr. Han performed an internal medicine residency at Saint Francis Hospital, now called Ascension Saint Francis Hospital, in Evanston, IL. After completing his residency, he served as an assistant professor and an attending physician at Southern Illinois University, then joined the bone marrow transplant program as a hospitalist and clinical instructor at Washington University in St. Louis, MO. Dr. Han then pursued advanced training with a fellowship in hematology-oncology at the University of Minnesota in Minneapolis. He was honored with an award as an outstanding fellow from the Minnesota Society of Oncology for two consecutive years. Following his fellowship, Dr. Han joined ACOHA in 2020.Fluent in English and Korean, Dr. Han is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American College of Physicians, the Society of Hospital Medicine, and the Korean Medical Association. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Han is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Pleuropulmonary Blastoma, Paget Disease of the Breast, Pulmonary Embolism, and Bone Marrow Aspiration. Dr. Han is board certified in American Board Of Internal Medicine. Dr. Han is currently accepting new patients.

Scott Richard is an Oncologist practicing medicine in Florham Park, New Jersey. Dr. Richard is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Oophorectomy.

Darlene Gibbon is a Palliative Medicine provider practicing medicine in Florham Park, New Jersey. Dr. Gibbon is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Malignant Mixed Mullerian Tumor, and Ovarian Cancer.

Bohdan Halibey is an Oncologist practicing medicine in Sparta, New Jersey. Dr. Halibey is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, Severe Congenital Neutropenia, and Bone Marrow Aspiration.

Steven Papish is an Internal Medicine provider practicing medicine in Florham Park, New Jersey. Dr. Papish is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Non-Hodgkin Lymphoma, and Small Lymphocytic Lymphoma (SLL).

Aisha Masood is a Hematologist and an Internal Medicine provider practicing medicine in Morristown, New Jersey. Dr. Masood is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Masood is board certified in American Board Of Internal Medicine. Dr. Masood is currently accepting new patients.

Dagmar Oette is an Oncologist practicing medicine in Ledgewood, New Jersey.